• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » CSSi LifeSciences, the Prince William Science Accelerator partner

CSSi LifeSciences, the Prince William Science Accelerator partner

April 7, 2017
CenterWatch Staff

CSSi LifeSciences, a partner from discovery to commercialization for biologics and vaccines, is partnering with the Prince William Science Accelerator, a public-private, commercially available wet lab space in Northern Virginia. The partnership promotes the development of new businesses and the retention and expansion of existing businesses within the county's growing and diverse life sciences community through CSSi LifeSciences' technical assistance, regulatory, clinical and commercial assessment for all Prince William Science Accelerator tenants.

The preclinical, regulatory and clinical expertise of CSSi LifeSciences combined with the Prince William Science Accelerator's innovative wet lab space will allow startup life sciences and biotechnology companies to have access to talent, multiple opportunities for collaboration and incredible prospect for expanded growth within the life sciences industry in the County. More specifically, the strategic partnership will deliver a productive environment and speed-to-market solutions to wet lab tenants through the use of unparalleled services and strategies and readily available space and equipment, as well as by providing access to industry networks, partnerships and internships.

"We are excited about partnering with the Prince William Science Accelerator and extending our reach into the Virginia market," said Jim Sergi, president, CSSi LifeSciences. "With Prince William County's already well-established and growing life sciences ecosystem, we are committed to providing the Science Accelerator with the necessary services and resources needed to help add to its growing portfolio of wet lab tenants. Together, we are the ideal solution for bringing life sciences companies' innovations to market faster and more cost-effectively."

"The Prince William Science Accelerator has strong market appeal, as there is no other space like it in the region. Partnering with CSSi LifeSciences further enhances our unique offering and pro-business support that Prince William County is recognized for," said Jeffrey A. Kaczmarek, executive director, Prince William County Department of Economic Development.

Over the years, CSSi LifeSciences has provided vital business and strategic support to "Big" biopharma, as well as incubators, and enabled the development of over 500 drugs, biologics and in vitro diagnostics. CSSi LifeSciences has a defined process that lets its clients leverage its breadth of integrated services and growth strategies to develop strategic regulatory and clinical pathways to ensure commercial success and maximize shareholder value.

First established in 2014, the Prince William Science Accelerator was designed to provide an innovative environment for entrepreneurial research and product development. Ideally situated in Innovation Park near George Mason University, the 9,000 sq. ft. facility houses nine fully built-out wet laboratory spaces suited for each tenant's specific needs. The Science Accelerator is amongst the largest and fastest-growing cluster of life and forensic sciences facilities in the region.

Upcoming Events

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Five Ws

    Consider the Five ‘W’s to Understand Potential Participants

  • QandA-360x240.png

    Perspectives from Smaller-Sized CROs: Q&A with Cheryle Evans

  • White House

    Trial Stakeholders Advise White House on Emergency Research Infrastructure

  • SurveywBlueBackground-360x240.png

    Stress Levels Continue to Climb in Healthcare Workforce, Survey Finds

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing